Literature DB >> 27613022

[Actinic keratoses].

T Hommel1, R-M Szeimies2.   

Abstract

Actinic keratosis (AK) is a very common skin diagnosis in office-based dermatology. Due to the demographic changes with increasing numbers of elderly people, the proportion of patients with AK is expected rise. In order to avoid progression into squamous cell carcinoma, early treatment is recommended. Numerous treatment options are currently available for this purpose. In addition to targeted therapies for isolated AK many field-directed treatment modalities are available. However, the treatment option that is finally chosen depends on a variety of factors (e.g., age of the patient, the extent of the clinical findings) and the patient's needs and therefore has to be customized.

Entities:  

Keywords:  Field-directed treatment; Keratinocytes; Lesions; Precancerous conditions; Squamous cell carcinoma

Mesh:

Year:  2016        PMID: 27613022     DOI: 10.1007/s00105-016-3873-4

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  85 in total

1.  Multifocal epithelial tumors and field cancerization from loss of mesenchymal CSL signaling.

Authors:  Bing Hu; Einar Castillo; Louise Harewood; Paola Ostano; Alexandre Reymond; Reinhard Dummer; Wassim Raffoul; Wolfram Hoetzenecker; Günther F L Hofbauer; G Paolo Dotto
Journal:  Cell       Date:  2012-06-08       Impact factor: 41.582

2.  A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe.

Authors:  R M Szeimies
Journal:  J Eur Acad Dermatol Venereol       Date:  2015-06-15       Impact factor: 6.166

3.  Dosing with 5% imiquimod cream 3 times per week for the treatment of actinic keratosis: results of two phase 3, randomized, double-blind, parallel-group, vehicle-controlled trials.

Authors:  Neil Korman; Ron Moy; Mark Ling; Robert Matheson; Stacy Smith; Scott McKane; James H Lee
Journal:  Arch Dermatol       Date:  2005-04

4.  Ras gene mutation and amplification in human nonmelanoma skin cancers.

Authors:  W E Pierceall; L H Goldberg; M A Tainsky; T Mukhopadhyay; H N Ananthaswamy
Journal:  Mol Carcinog       Date:  1991       Impact factor: 4.784

5.  A Retrospective Study of Treatment of Squamous Cell Carcinoma In situ.

Authors:  Meri Övermark; Sari Koskenmies; Sari Pitkänen
Journal:  Acta Derm Venereol       Date:  2016-01       Impact factor: 4.437

6.  [Solar ultraviolet radiation risk in outdoor workers: a specific project of Tuscany Region (Italy)].

Authors:  Lucia Miligi; Alessandra Benvenuti; Patrizia Legittimo; Anna Maria Badiali; Valentina Cacciarini; Alessandra Chiarugi; Emanuele Crocetti; Simona Alberghini Maltoni; Iole Pinto; Gaetano Zipoli; Daniele Grifoni; Francesco Carnevale; Nicola Pimpinelli; Francesca Cherubini Di Simplicio; Sara Poggiali; Pietro Sartorelli; Riccardo Sirna; Rodolfo Amati; Letizia Centi; Gianluca Festa; Carla Fiumalbi; Aldo Fedi; Senio Giglioli; Rossana Mancini; Tina Panzone; Giuseppe Petrioli; Alessandra Trombetti; Daniela Volpi
Journal:  Epidemiol Prev       Date:  2013 Jan-Feb       Impact factor: 1.901

Review 7.  Cryosurgery for common skin conditions.

Authors:  Mark D Andrews
Journal:  Am Fam Physician       Date:  2004-05-15       Impact factor: 3.292

8.  Tumor evolution. High burden and pervasive positive selection of somatic mutations in normal human skin.

Authors:  Iñigo Martincorena; Amit Roshan; Moritz Gerstung; Peter Ellis; Peter Van Loo; Stuart McLaren; David C Wedge; Anthony Fullam; Ludmil B Alexandrov; Jose M Tubio; Lucy Stebbings; Andrew Menzies; Sara Widaa; Michael R Stratton; Philip H Jones; Peter J Campbell
Journal:  Science       Date:  2015-05-22       Impact factor: 47.728

9.  Histopathological analysis of the therapeutic response to cryotherapy with liquid nitrogen in patients with multiple actinic keratosis.

Authors:  Marina Câmara de Oliveira; Flávia Trevisan; Clovis Antônio Lopes Pinto; Célia Antônia Xavier; Jaqueline Campoi Calvo Lopes Pinto
Journal:  An Bras Dermatol       Date:  2015-06-01       Impact factor: 1.896

10.  Combined CSL and p53 downregulation promotes cancer-associated fibroblast activation.

Authors:  Maria-Giuseppina Procopio; Csaba Laszlo; Dania Al Labban; Dong Eun Kim; Pino Bordignon; Seung-Hee Jo; Sandro Goruppi; Elena Menietti; Paola Ostano; Ugo Ala; Paolo Provero; Wolfram Hoetzenecker; Victor Neel; Witold W Kilarski; Melody A Swartz; Cathrin Brisken; Karine Lefort; G Paolo Dotto
Journal:  Nat Cell Biol       Date:  2015-08-24       Impact factor: 28.824

View more
  2 in total

Review 1.  [The aged scalp : A dermato-oncological focus point].

Authors:  N Wroblewski; K Wylon; C Ulrich
Journal:  Hautarzt       Date:  2017-06       Impact factor: 0.751

Review 2.  [Non-melanoma skin cancer : Pathogenesis, prevalence and prevention].

Authors:  A Zink
Journal:  Hautarzt       Date:  2017-11       Impact factor: 0.751

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.